Auszug:
Stegmayr, Stoffels, Filss, Heinzel, Lohmann, Willuweit, ... , Langen. (2020). Current trends in the use of O-(2-[(18)F]fluoroethyl)-L-tyrosine ([(18)F]FET) in neurooncology. Nucl Med Biol
Stegmayr, Surges, Choi, Burda, Stoffels, Filss, ... , Langen. (2020). Investigation of Cerebral O-(2-[(18)F]Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models. Mol Imaging Biol
Geisler, Stegmayr, Niemitz, Lohmann, Rapp, Stoffels, ... , Langen. (2019). Treatment-Related Uptake of O-(2-(18)F-Fluoroethyl)-l-Tyrosine and l-[Methyl-(3)H]-Methionine After Tumor Resection in Rat Glioma Models. J Nucl Med, 60(10), 1373-9
Stegmayr, Stoffels, Kops, Lohmann, Galldiks, Shah, ... , Langen. (2019). Influence of Dexamethasone on O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake. Mol Imaging Biol, 21(1), 168-74
Stegmayr, Willuweit, Lohmann, & Langen. (2019). O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results. Curr Radiopharm, 12(3), 201-10
Willuweit, Lohmann, & Stegmayr. (2019). CHAPTER 19 Preclinical Applications of MR-PET. In Hybrid MR-PET Imaging: Systems, Methods and Applications (pp. 368-78): The Royal Society of Chemistry.
Stegmayr, Bandelow, Oliveira, Lohmann, Willuweit, Filss, ... , Langen. (2017). Influence of blood-brain barrier permeability on O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in rat gliomas. Eur J Nucl Med Mol Imaging, 44(3), 408-16
Stegmayr, Oliveira, Niemietz, Willuweit, Lohmann, Galldiks, ... , Langen. (2017). Influence of Bevacizumab on Blood-Brain Barrier Permeability and O-(2-(18)F-Fluoroethyl)-l-Tyrosine Uptake in Rat Gliomas. J Nucl Med, 58(5), 700-5